Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Eva Hoster, Marek Trněný et al.|The Lancet|2024Cited by 135
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell LymphomaStefan Alig, Ash A. Alizadeh, Charles Macaulay et al.|Journal of Clinical Oncology|2021Cited by 78
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesNader Hirmas, Wolfgang P. Fendler, Rainer Hamacher et al.|Journal of Nuclear Medicine|2022Cited by 68
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patientsMaria C. Ferrández, Ronald Boellaard, Sandeep S.V. Golla et al.|Scientific Reports|2023Cited by 34